B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.
about
Impact of age at administration, lysosomal storage, and transgene regulatory elements on AAV2/8-mediated rat liver transductionInhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectorsGene therapeutic approach using mutation-adapted U1 snRNA to correct a RPGR splice defect in patient-derived cells.Lentiviral vectors for immune cells targeting.Physiological and tissue-specific vectors for treatment of inherited diseases.Repopulation of B-lymphocytes with restricted gene expression using haematopoietic stem cells engineered with lentiviral vectors.A tissue-specific, activation-inducible, lentiviral vector regulated by human CD40L proximal promoter sequences.Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA.Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors.Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression.Self-inactivating retroviral vectors with improved RNA processing.Elements of lentiviral vector design toward gene therapy for treating mucopolysaccharidosis I.Regulated expression of murine CD40L by a lentiviral vector transcriptionally targeted through its endogenous promoter.Functional response to SDF1 alpha through over-expression of CXCR4 on adult subventricular zone progenitor cells.U1 snRNA-mediated gene therapeutic correction of splice defects caused by an exceptionally mild BBS mutation.
P2860
Q27307010-6BD90F0B-B719-4309-B2CC-AB4ECA268ABFQ34715929-1A3B6280-8557-407F-96FD-B76EFF17A7E1Q34994553-B5D9525A-06CA-426B-9E4B-92F007432F6EQ37677792-0A2A8402-F67F-4886-A7EB-74B3D6A522DFQ37801839-DE870905-C4EE-441C-A991-AA97A03EA5A7Q38477522-81A188BA-080C-4208-92FF-53BDEAFB4268Q39627668-CB260753-7F03-4D08-A4DB-F3C3304AAB5EQ40005186-F8E5ACA8-D307-466D-9151-4A5534FE86CAQ40081805-9E25EA80-FBE1-4B78-934D-2613F568BF94Q40269711-B7AEC081-77EB-4641-9A8B-D2ACC2865231Q40365103-B78C94EC-1135-4088-AB3D-C2C511FCD43FQ40515056-A9F4ECDB-B463-4A90-ADC5-1C625C7CD914Q40609634-49ACAAD4-0473-47BE-93B5-00998B26189BQ41533331-2980A2DD-C2A9-41BD-A671-FC35ECC153DAQ42535636-D35A9B48-2ED6-40AA-A5E0-FF890FBF545EQ45869556-0A3696F5-AF78-42BC-9234-11E69C690D67
P2860
B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
B-cell-specific transgene expr ...... criptional regulatory element.
@en
B-cell-specific transgene expr ...... criptional regulatory element.
@nl
type
label
B-cell-specific transgene expr ...... criptional regulatory element.
@en
B-cell-specific transgene expr ...... criptional regulatory element.
@nl
prefLabel
B-cell-specific transgene expr ...... criptional regulatory element.
@en
B-cell-specific transgene expr ...... criptional regulatory element.
@nl
P2093
P2860
P356
P1433
P1476
B-cell-specific transgene expr ...... criptional regulatory element.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3302255
P577
2004-06-01T00:00:00Z